Galapagos, a fully integrated biotechnology company, has increased share capital through a subscription rights issue. The firm has issued 61,560 new ordinary shares for a total capital increase (including issuance premium)…
Galapagos, a fully integrated biotechnology company, has increased share capital through a subscription rights issue. The firm has issued 61,560 new ordinary shares for a total capital increase (including issuance premium)…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference